Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed...
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
About this item
Full title
Author / Creator
Xia, Zhongjun , Leng, Yun , Fang, Baijun , Liang, Yang , Li, Wei , Fu, Chengcheng , Yang, Linhua , Ke, Xiaoyan , Jiang, Hua , Weng, Jianyu , Liu, Li , Zhao, Yaozhong , Zhang, Xuejun , Huang, Zhongxia , Liu, Aichun , Shi, Qingzhi , Gao, Yuhuan , Chen, Xiequn , Pan, Ling , Cai, Zhen , Wang, Zhao , Wang, Yafei , Fan, Yaqun , Hou, Ming , Ma, Yigai , Hu, Jianda , Liu, Jing , Zhou, Jianfeng , Zhang, Xiaohong , Meng, Haitao , Lu, Xuzhang , Li, Fei , Ren, Hanyun , Huang, Bintao , Shao, Zonghong , Zhou, Hebing , Hu, Yu , Yang, Shifang , Zheng, Xiangjun , Wei, Peng , Pang, Hongyan , Yu, Wei , Liu, Yuzhang , Gao, Sujun , Yan, Lingzhi , Ma, Yanping , Jing, Hongmei , Du, Juan , Ling, Wei , Zhang, Jingyi , Sui, Weiwei , Wang, Fuxu , Li, Xin and Chen, Wenming
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Aponermin, a circularly permuted tumor necrosis factor-related apoptosis-inducing ligand, is a potential death receptor 4/5-targeted antitumour candidate. Previous phase 1/2 studies have demonstrated the efficacy of aponermin in patients with relapsed or refractory multiple myeloma (RRMM). To confirm the superiority of aponermin plus tha...
Alternative Titles
Full title
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Leng, Yun
Fang, Baijun
Liang, Yang
Li, Wei
Fu, Chengcheng
Yang, Linhua
Ke, Xiaoyan
Jiang, Hua
Weng, Jianyu
Liu, Li
Zhao, Yaozhong
Zhang, Xuejun
Huang, Zhongxia
Liu, Aichun
Shi, Qingzhi
Gao, Yuhuan
Chen, Xiequn
Pan, Ling
Cai, Zhen
Wang, Zhao
Wang, Yafei
Fan, Yaqun
Hou, Ming
Ma, Yigai
Hu, Jianda
Liu, Jing
Zhou, Jianfeng
Zhang, Xiaohong
Meng, Haitao
Lu, Xuzhang
Li, Fei
Ren, Hanyun
Huang, Bintao
Shao, Zonghong
Zhou, Hebing
Hu, Yu
Yang, Shifang
Zheng, Xiangjun
Wei, Peng
Pang, Hongyan
Yu, Wei
Liu, Yuzhang
Gao, Sujun
Yan, Lingzhi
Ma, Yanping
Jing, Hongmei
Du, Juan
Ling, Wei
Zhang, Jingyi
Sui, Weiwei
Wang, Fuxu
Li, Xin
Chen, Wenming
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b54d9a34e0c7454a9a0589390ee8abee
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b54d9a34e0c7454a9a0589390ee8abee
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-023-11489-8
